20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

What Is BioGenerator?

BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.

BioGenerator is the investment arm of BioSTL

Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarza’s products and services utilize its proprietary Arrayed Imaging Reflectometry™ (“AIR”) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research.

Our Companies

The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Our Companies

The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

BioGenerator Wins Federal Grant to Build New St. Louis Bioscience Companies09/26/2017

BioGenerator supported startup Disarm Therapeutics announces $30M financing09/19/2017

BioGenerator Company Cofactor Genomics Announces $18M Series-A Round to Bring RNA to Precision Medicine09/18/2017

BioGenerator Co-Leads Seed Round for Washington University Company SentiAR09/12/2017

BioGenerator Company Confluence Life Sciences Acquired By Aclaris Therapeutics08/08/2017

BioGenerator Supported Startup Precision Virologics Receives Investment From Oncolys BioPharma03/29/2017

BIOGENERATOR COMPANY BENSON HILL BIOSYSTEMS RAISES $25M SERIES B03/28/2017

BioGenerator Company Canopy Biosciences Charts Quick Path To Revenue03/07/2017

See All News

What Others Are Saying

Joseph Monahan
Jon Root
Matt Crisp

Stay Updated

Stay up to date with the latest BioGenerator news and details.